Zai Lab

Yahoo Finance • 29 days ago

China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order

Biotech stocks Zai Labs and BeOne Medicines plummeted Wednesday on reports President Donald Trump will issue an executive order to reduce U.S. access to drugs developed in China. Continue Reading View Comments... Full story

Yahoo Finance • last month

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLAB

NEW YORK, Sept. 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ: ZLAB).  Such investors are advised to contact Danielle Peyton at newactio... Full story

Yahoo Finance • 2 months ago

Jefferies assumes coverage on Zai Lab stock with Buy rating, $52 price target

Investing.com - Jefferies has assumed coverage on Zai Lab (NASDAQ:ZLAB) with a Buy rating and a price target of $52.00. The company, currently valued at approximately $4 billion, has seen its shares trade between $17.50 and $44.34 over t... Full story

Yahoo Finance • 2 months ago

Zai Lab Q2 2025 Earnings Preview

* Zai Lab (NASDAQ:ZLAB [https://seekingalpha.com/symbol/ZLAB]) is scheduled to announce Q2 earnings results on Thursday, August 7th, before market open. * The consensus EPS Estimate is -$0.42 [https://seekingalpha.com/symbol/ZLAB/earni... Full story

Yahoo Finance • 3 months ago

AstraZeneca succeeds in late-stage trial for myasthenia gravis therapy

[Prime Minister Scott Morrison Announces Deal With AstraZeneca To Supply Potential COVID-19 Vaccine] Lisa Maree Williams/Getty Images News AstraZeneca (NASDAQ:AZN [https://seekingalpha.com/symbol/AZN]) announced Thursday that gefurulimab,... Full story

Yahoo Finance • 4 months ago

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis

Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 biotech stocks screaming a buy. On June 17, the company delivered positive trial results from a preclinical study of ZL-1503, a promising IL-13/IL-31R bispecific antibody.Zai Lab (ZLAB) Delive... Full story

Yahoo Finance • 5 months ago

Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer

- The Company is on track to initiate a pivotal study for ZL-1310 in small cell lung cancer (SCLC) in 2025 SHANGHAI & CAMBRIDGE, Mass., May 19, 2025--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the U.S. Foo... Full story

Yahoo Finance • 5 months ago

Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts

We recently published a list of 11 Best Breakout Stocks to Buy According to Analysts. In this article, we are going to take a look at where Zai Lab Limited (NASDAQ:ZLAB) stands against other best breakout stocks to buy according to analyst... Full story

Yahoo Finance • 6 months ago

Zai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff Rollout

We recently published a list of 10 Stocks Insiders Sold in April After Trump’s Tariff Rollout. In this article, we are going to take a look at where Zai Lab Limited (NASDAQ:ZLAB) stands against other stocks that insiders sold in April afte... Full story

Yahoo Finance • last year

Zai Lab to Present Preclinical Data of ZL-1503, an IL-13/IL-31 Bispecific Antibody for the Treatment of Atopic Dermatitis, at EADV Congress 2024

Late-breaking oral presentation will discuss the potential of ZL-1503 as a novel treatment for moderate-to-severe atopic dermatitis and other diseases involving the IL-13 and IL-31 pathways ZL-1503 is part of Zai Lab’s internally discover... Full story

Yahoo Finance • last year

Zai Lab Announces Dr. Harald Reinhart to Retire as Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases; Dr. Rafael Amado to be Appointed President, Head of Global R&D

SHANGHAI & CAMBRIDGE, Mass., June 11, 2024--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) announced today that following a distinguished career, Harald Reinhart, M.D., President, Head of Global Development, Neuroscience, Auto... Full story

Yahoo Finance • 2 years ago

Zai Lab Ltd (ZLAB) Reports 25% Year-Over-Year Revenue Growth in Full-Year 2023 Financial Results

Total Revenue: Zai Lab Ltd (NASDAQ:ZLAB) reported a 25% increase in product revenue, reaching $266.7 million for the full year of 2023. Net Loss Improvement: Net loss decreased to $334.6 million in 2023 from $443.3 million in the previous... Full story

Yahoo Finance • 2 years ago

Zai Lab Announces the First Listing of VYVGART® (efgartigimod alfa injection) and Other Updates in China’s National Reimbursement Drug List

SHANGHAI & CAMBRIDGE, Mass., December 13, 2023--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the 2023 National Reimbursement Drug List (NRDL) released by China’s National Healthcare Security Administrati... Full story

Yahoo Finance • 2 years ago

Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates

Zai Lab Limited Total product revenue of $69.2 million for the third quarter of 2023, representing 22% y-o-y growth; 27% y-o-y growth at constant exchange rate (CER) VYVGART® (efgartigimod alfa injection) achieved $4.9 million sales sinc... Full story

Yahoo Finance • 2 years ago

13 Stocks to Buy with Exponential Growth

In this article, we will take a look at the 13 stocks to buy with exponential growth. To see more such companies, go directly to 5 Stocks to Buy with Exponential Growth. Optimism was prevailing in the US stock market on October 11 as inve... Full story

Yahoo Finance • 2 years ago

Why Shares of Zai Lab Limited Were Jumping on Tuesday

Shares of Zai Lab (NASDAQ: ZLAB) were up more than 10% as of 11 a.m. on Tuesday. The Chinese biotech stock rose after the company announced positive phase 3 trial data regarding Tivdak as a front-line therapy to treat metastatic cervical c... Full story

Yahoo Finance • 2 years ago

11 Most Profitable Biotech Stocks Today

In this piece, we will take a look at the 11 most profitable biotechnology stocks to buy today. If you want to skip our introduction to the biotechnology industry and want to take a look at the top five stocks in this list, then head on ov... Full story

Yahoo Finance • 2 years ago

Bragar Eagel & Squire, P.C. Is Investigating Xponential, Franchise Group, Zai Lab, and Alvotech and Encourages Investors to Contact the Firm

NEW YORK, July 10, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Xponential Fitness, Inc. (NYSE: XPOF), Franchise Group, Inc. (NASDAQ:... Full story

Yahoo Finance • 2 years ago

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Zai Lab Limited Investors to Inquire About Securities Class Action Investigation – ZLAB

NEW YORK, July 01, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zai Lab Limited (NASDAQ: ZLAB) resulting from all... Full story

Yahoo Finance • 2 years ago

Bragar Eagel & Squire, P.C. Is Investigating Xponential, Franchise Group, Zai Lab, and Hayward and Encourages Investors to Contact the Firm

NEW YORK, June 30, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Xponential Fitness, Inc. (NYSE: XPOF), Franchise Group, Inc. (NASDAQ:... Full story